

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | endothelium development (GO:0003158) | 5.51693463 |
| 2 | collagen fibril organization (GO:0030199) | 5.40075354 |
| 3 | chondrocyte proliferation (GO:0035988) | 5.09314471 |
| 4 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 4.80471949 |
| 5 | negative regulation of fatty acid transport (GO:2000192) | 4.74704211 |
| 6 | protein heterotrimerization (GO:0070208) | 4.58430886 |
| 7 | cellular glucuronidation (GO:0052695) | 4.32627488 |
| 8 | substrate-dependent cell migration (GO:0006929) | 4.28494213 |
| 9 | glucuronate metabolic process (GO:0019585) | 4.17286978 |
| 10 | uronic acid metabolic process (GO:0006063) | 4.17286978 |
| 11 | kidney mesenchyme development (GO:0072074) | 4.16174948 |
| 12 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 4.10658328 |
| 13 | cartilage development involved in endochondral bone morphogenesis (GO:0060351) | 4.07888766 |
| 14 | low-density lipoprotein particle clearance (GO:0034383) | 3.98127250 |
| 15 | cell migration involved in heart development (GO:0060973) | 3.91256935 |
| 16 | sequestering of extracellular ligand from receptor (GO:0035581) | 3.87836875 |
| 17 | mesenchymal-epithelial cell signaling (GO:0060638) | 3.86505304 |
| 18 | positive regulation of blood vessel endothelial cell migration (GO:0043536) | 3.84871805 |
| 19 | regulation of plasminogen activation (GO:0010755) | 3.79079720 |
| 20 | neuron projection extension involved in neuron projection guidance (GO:1902284) | 3.76842283 |
| 21 | axon extension involved in axon guidance (GO:0048846) | 3.76842283 |
| 22 | xenobiotic catabolic process (GO:0042178) | 3.75298905 |
| 23 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan (GO:0019800) | 3.74387143 |
| 24 | epoxygenase P450 pathway (GO:0019373) | 3.73504731 |
| 25 | positive regulation of endothelial cell apoptotic process (GO:2000353) | 3.73482564 |
| 26 | artery development (GO:0060840) | 3.73345410 |
| 27 | negative regulation of adherens junction organization (GO:1903392) | 3.70887138 |
| 28 | negative regulation of focal adhesion assembly (GO:0051895) | 3.70887138 |
| 29 | negative regulation of cell junction assembly (GO:1901889) | 3.70887138 |
| 30 | positive regulation of endothelial cell differentiation (GO:0045603) | 3.68508763 |
| 31 | venous blood vessel morphogenesis (GO:0048845) | 3.64286247 |
| 32 | sprouting angiogenesis (GO:0002040) | 3.57568705 |
| 33 | negative regulation of blood vessel endothelial cell migration (GO:0043537) | 3.55715623 |
| 34 | positive regulation of cartilage development (GO:0061036) | 3.53258123 |
| 35 | apoptotic cell clearance (GO:0043277) | 3.51836648 |
| 36 | metanephric mesenchyme development (GO:0072075) | 3.50446425 |
| 37 | regulation of chemokine-mediated signaling pathway (GO:0070099) | 3.47895629 |
| 38 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 3.46941766 |
| 39 | lymph vessel development (GO:0001945) | 3.46408233 |
| 40 | positive regulation of fibroblast migration (GO:0010763) | 3.44091017 |
| 41 | positive regulation of endothelial cell migration (GO:0010595) | 3.41796322 |
| 42 | endodermal cell differentiation (GO:0035987) | 3.40319797 |
| 43 | vascular endothelial growth factor receptor signaling pathway (GO:0048010) | 3.39562215 |
| 44 | basement membrane organization (GO:0071711) | 3.38637161 |
| 45 | glomerular basement membrane development (GO:0032836) | 3.38369956 |
| 46 | collagen metabolic process (GO:0032963) | 3.36346510 |
| 47 | positive regulation of extracellular matrix organization (GO:1903055) | 3.34811302 |
| 48 | hyaluronan catabolic process (GO:0030214) | 3.34644559 |
| 49 | positive regulation of receptor recycling (GO:0001921) | 3.33585429 |
| 50 | regulation of tight junction assembly (GO:2000810) | 3.33453642 |
| 51 | regulation of branching involved in salivary gland morphogenesis (GO:0060693) | 3.33063748 |
| 52 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger (GO:0007199 | 3.30928228 |
| 53 | negative regulation of nitric-oxide synthase activity (GO:0051001) | 3.29491865 |
| 54 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.29374566 |
| 55 | glomerular filtration (GO:0003094) | 3.28133378 |
| 56 | negative regulation of endothelial cell proliferation (GO:0001937) | 3.26854254 |
| 57 | multicellular organismal macromolecule metabolic process (GO:0044259) | 3.23855594 |
| 58 | collagen catabolic process (GO:0030574) | 3.18958208 |
| 59 | regulation of glomerular filtration (GO:0003093) | 3.18453876 |
| 60 | cell-substrate junction assembly (GO:0007044) | 3.17502314 |
| 61 | positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862) | 3.15784269 |
| 62 | outer ear morphogenesis (GO:0042473) | 3.15126348 |
| 63 | multicellular organismal metabolic process (GO:0044236) | 3.15063267 |
| 64 | bone trabecula formation (GO:0060346) | 3.13827388 |
| 65 | regulation of cell migration involved in sprouting angiogenesis (GO:0090049) | 3.12426615 |
| 66 | regulation of blood vessel endothelial cell migration (GO:0043535) | 3.11935315 |
| 67 | lymphangiogenesis (GO:0001946) | 3.11159740 |
| 68 | regulation of integrin-mediated signaling pathway (GO:2001044) | 3.08539773 |
| 69 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 3.07176808 |
| 70 | extracellular matrix assembly (GO:0085029) | 3.06670002 |
| 71 | positive regulation of epithelial cell migration (GO:0010634) | 3.06183713 |
| 72 | extracellular matrix disassembly (GO:0022617) | 3.05951565 |
| 73 | positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G- | 3.04929464 |
| 74 | blood vessel remodeling (GO:0001974) | 3.04575376 |
| 75 | positive regulation of gastrulation (GO:2000543) | 3.04387040 |
| 76 | skin morphogenesis (GO:0043589) | 3.04294811 |
| 77 | keratan sulfate catabolic process (GO:0042340) | 3.03712423 |
| 78 | endothelial cell morphogenesis (GO:0001886) | 3.03173433 |
| 79 | endothelial tube morphogenesis (GO:0061154) | 3.01377429 |
| 80 | morphogenesis of an endothelium (GO:0003159) | 3.01377429 |
| 81 | hemidesmosome assembly (GO:0031581) | 3.00845016 |
| 82 | regulation of transforming growth factor beta1 production (GO:0032908) | 3.00307682 |
| 83 | * negative regulation of chondrocyte differentiation (GO:0032331) | 2.98973675 |
| 84 | multicellular organismal catabolic process (GO:0044243) | 2.98613446 |
| 85 | regulation of skeletal muscle contraction (GO:0014819) | 2.96651901 |
| 86 | angiogenesis involved in wound healing (GO:0060055) | 2.95733956 |
| 87 | Golgi transport vesicle coating (GO:0048200) | 2.94538976 |
| 88 | COPI coating of Golgi vesicle (GO:0048205) | 2.94538976 |
| 89 | protein retention in ER lumen (GO:0006621) | 2.93887998 |
| 90 | induction of positive chemotaxis (GO:0050930) | 2.93528412 |
| 91 | membrane raft organization (GO:0031579) | 2.93482087 |
| 92 | cell migration involved in sprouting angiogenesis (GO:0002042) | 2.91968587 |
| 93 | endothelial cell proliferation (GO:0001935) | 2.90522284 |
| 94 | hippo signaling (GO:0035329) | 2.90226973 |
| 95 | neuron remodeling (GO:0016322) | 2.90173384 |
| 96 | positive regulation of urine volume (GO:0035810) | 2.89837944 |
| 97 | regulation of endothelial cell differentiation (GO:0045601) | 2.89146244 |
| 98 | positive regulation of odontogenesis (GO:0042482) | 2.87507063 |
| 99 | endocardial cushion development (GO:0003197) | 2.86985460 |
| 100 | cell proliferation involved in metanephros development (GO:0072203) | 2.86227774 |
| 101 | atrioventricular valve morphogenesis (GO:0003181) | 2.84077212 |
| 102 | positive regulation of osteoblast proliferation (GO:0033690) | 2.82791883 |
| 103 | positive regulation of fatty acid oxidation (GO:0046321) | 2.82167323 |
| 104 | response to magnesium ion (GO:0032026) | 2.81720510 |
| 105 | peptidyl-proline hydroxylation (GO:0019511) | 2.81049408 |
| 106 | * regulation of chondrocyte differentiation (GO:0032330) | 2.80747478 |
| 107 | negative regulation of complement activation (GO:0045916) | 2.79434020 |
| 108 | wound healing, spreading of cells (GO:0044319) | 2.78702732 |
| 109 | dichotomous subdivision of an epithelial terminal unit (GO:0060600) | 2.78536264 |
| 110 | dermatan sulfate biosynthetic process (GO:0030208) | 2.78429332 |
| 111 | L-ascorbic acid metabolic process (GO:0019852) | 2.77062860 |
| 112 | cell adhesion mediated by integrin (GO:0033627) | 2.76800315 |
| 113 | substrate adhesion-dependent cell spreading (GO:0034446) | 2.76024515 |
| 114 | regulation of endothelial cell migration (GO:0010594) | 2.75551229 |
| 115 | positive regulation of cardiac muscle hypertrophy (GO:0010613) | 2.75120516 |
| 116 | positive regulation of muscle hypertrophy (GO:0014742) | 2.75120516 |
| 117 | cellular response to vascular endothelial growth factor stimulus (GO:0035924) | 2.74621583 |
| 118 | blood vessel endothelial cell migration (GO:0043534) | 2.73727300 |
| 119 | negative regulation of endothelial cell migration (GO:0010596) | 2.73610019 |
| 120 | negative regulation of cell-matrix adhesion (GO:0001953) | 2.73541830 |
| 121 | positive regulation of chondrocyte differentiation (GO:0032332) | 2.73137506 |
| 122 | white fat cell differentiation (GO:0050872) | 2.72680179 |
| 123 | ovulation cycle (GO:0042698) | 2.71494591 |
| 124 | pattern specification involved in kidney development (GO:0061004) | 2.69568931 |
| 125 | craniofacial suture morphogenesis (GO:0097094) | 2.69180430 |
| 126 | vascular endothelial growth factor signaling pathway (GO:0038084) | 2.68097251 |
| 127 | epithelial cell-cell adhesion (GO:0090136) | 2.67304720 |
| 128 | wound healing, spreading of epidermal cells (GO:0035313) | 2.65820627 |
| 129 | regulation of phospholipase A2 activity (GO:0032429) | 2.65778719 |
| 130 | * regulation of cartilage development (GO:0061035) | 2.64416482 |
| 131 | regulation of gastrulation (GO:0010470) | 2.63527846 |
| 132 | omega-hydroxylase P450 pathway (GO:0097267) | 2.63213783 |
| 133 | embryonic cranial skeleton morphogenesis (GO:0048701) | 2.62755134 |
| 134 | positive regulation of p38MAPK cascade (GO:1900745) | 2.61047282 |
| 135 | cellular response to interferon-alpha (GO:0035457) | 2.60808884 |
| 136 | branching involved in salivary gland morphogenesis (GO:0060445) | 2.60533531 |
| 137 | protein localization to cell surface (GO:0034394) | 2.60491852 |
| 138 | negative regulation of leukocyte chemotaxis (GO:0002689) | 2.60272677 |
| 139 | middle ear morphogenesis (GO:0042474) | 2.59888318 |
| 140 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 2.59595381 |
| 141 | * extracellular matrix organization (GO:0030198) | 2.59197236 |
| 142 | protein targeting to plasma membrane (GO:0072661) | 2.58810827 |
| 143 | * extracellular structure organization (GO:0043062) | 2.57865616 |
| 144 | phagocytosis, recognition (GO:0006910) | 2.56306450 |
| 145 | extracellular fibril organization (GO:0043206) | 2.55312582 |
| 146 | renal filtration (GO:0097205) | 2.53343806 |
| 147 | blood vessel maturation (GO:0001955) | 2.53037243 |
| 148 | dermatan sulfate metabolic process (GO:0030205) | 2.52957927 |
| 149 | type B pancreatic cell proliferation (GO:0044342) | 2.52135767 |
| 150 | mesenchyme morphogenesis (GO:0072132) | 2.51369188 |
| 151 | fibril organization (GO:0097435) | 2.51171136 |
| 152 | muscle cell migration (GO:0014812) | 2.51058953 |
| 153 | * negative regulation of cartilage development (GO:0061037) | 2.49927208 |
| 154 | negative regulation of catenin import into nucleus (GO:0035414) | 2.48900517 |
| 155 | plasma membrane repair (GO:0001778) | 2.46890880 |
| 156 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.45404210 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * TRIM28_21343339_ChIP-Seq_HEK293_Human | 5.65403902 |
| 2 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 5.29031042 |
| 3 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 5.13461523 |
| 4 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 4.67899207 |
| 5 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.35715569 |
| 6 | CLOCK_20551151_ChIP-Seq_293T_Human | 4.02215394 |
| 7 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 3.17166754 |
| 8 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 2.87613370 |
| 9 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 2.46191022 |
| 10 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 2.42476658 |
| 11 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 2.38242346 |
| 12 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 2.38242346 |
| 13 | * CJUN_26792858_Chip-Seq_BT549_Human | 2.38203250 |
| 14 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 2.35096660 |
| 15 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 2.33500177 |
| 16 | * CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 2.29018808 |
| 17 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.24190505 |
| 18 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 2.22051121 |
| 19 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 2.09915185 |
| 20 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.07811222 |
| 21 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.03851665 |
| 22 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.96682219 |
| 23 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.92267966 |
| 24 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.87184996 |
| 25 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.82580537 |
| 26 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.81041196 |
| 27 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.80982990 |
| 28 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.77645022 |
| 29 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.77378034 |
| 30 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.77378034 |
| 31 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.72866856 |
| 32 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.66485934 |
| 33 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.65869504 |
| 34 | * BRD4_25478319_ChIP-Seq_HGPS_Human | 1.64456031 |
| 35 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.58539620 |
| 36 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.57110329 |
| 37 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.54467286 |
| 38 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.53961218 |
| 39 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.53839575 |
| 40 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.47319577 |
| 41 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.47178373 |
| 42 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.47132831 |
| 43 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.45475209 |
| 44 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.38718692 |
| 45 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.37996247 |
| 46 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.37335631 |
| 47 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.34539097 |
| 48 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.32954993 |
| 49 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.28553989 |
| 50 | TP53_16413492_ChIP-PET_HCT116_Human | 1.27774104 |
| 51 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.27159327 |
| 52 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.26743321 |
| 53 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.25879479 |
| 54 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.24930472 |
| 55 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.21514772 |
| 56 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.20904496 |
| 57 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 1.20107165 |
| 58 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.18059999 |
| 59 | SA1_22415368_ChIP-Seq_MEFs_Mouse | 1.17080624 |
| 60 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.17052593 |
| 61 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.16278400 |
| 62 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.15706687 |
| 63 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.13486545 |
| 64 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.11966913 |
| 65 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.11741775 |
| 66 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.10777608 |
| 67 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.10641331 |
| 68 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.10641331 |
| 69 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.10202676 |
| 70 | * P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.09878828 |
| 71 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 1.09511205 |
| 72 | * JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.09494123 |
| 73 | * GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.09388751 |
| 74 | * PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 1.09187363 |
| 75 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 1.09186834 |
| 76 | * AHR_22903824_ChIP-Seq_MCF-7_Human | 1.08634533 |
| 77 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 1.08471870 |
| 78 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.07363363 |
| 79 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.07315444 |
| 80 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.07001905 |
| 81 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.06239510 |
| 82 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.05932626 |
| 83 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.05767539 |
| 84 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.05767539 |
| 85 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.05697660 |
| 86 | ATF3_27146783_Chip-Seq_COLON_Human | 1.04146165 |
| 87 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.03587982 |
| 88 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.02848630 |
| 89 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.02823091 |
| 90 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.01635453 |
| 91 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 1.00944381 |
| 92 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.00707693 |
| 93 | KLF5_25053715_ChIP-Seq_YYC3_Human | 1.00690000 |
| 94 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 0.99545236 |
| 95 | TP53_22127205_ChIP-Seq_IMR90_Human | 0.99425284 |
| 96 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.98669278 |
| 97 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.98325046 |
| 98 | RXR_22108803_ChIP-Seq_LS180_Human | 0.98266296 |
| 99 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.96952446 |
| 100 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.96623030 |
| 101 | * ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.95024108 |
| 102 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.94557440 |
| 103 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.94041320 |
| 104 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.93927860 |
| 105 | * TP63_23658742_ChIP-Seq_EP156T_Human | 0.92680776 |
| 106 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.90737183 |
| 107 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.90714232 |
| 108 | * PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.90493591 |
| 109 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.90428781 |
| 110 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.90245709 |
| 111 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.89287532 |
| 112 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.89154323 |
| 113 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.88980770 |
| 114 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.88052614 |
| 115 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.85526790 |
| 116 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.84605066 |
| 117 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.84505092 |
| 118 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.83146061 |
| 119 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.82994951 |
| 120 | NFI_21473784_ChIP-Seq_ESCs_Mouse | 0.82815721 |
| 121 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.82122968 |
| 122 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 0.81520049 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0008438_abnormal_cutaneous_collagen | 7.21813198 |
| 2 | MP0005275_abnormal_skin_tensile | 5.15026820 |
| 3 | MP0003705_abnormal_hypodermis_morpholog | 4.98660730 |
| 4 | MP0005503_abnormal_tendon_morphology | 4.17071188 |
| 5 | MP0001958_emphysema | 4.00575480 |
| 6 | MP0003279_aneurysm | 3.64610232 |
| 7 | MP0009384_cardiac_valve_regurgitation | 3.60906730 |
| 8 | MP0002254_reproductive_system_inflammat | 2.97948704 |
| 9 | MP0004272_abnormal_basement_membrane | 2.84845347 |
| 10 | MP0002295_abnormal_pulmonary_circulatio | 2.20227676 |
| 11 | MP0010030_abnormal_orbit_morphology | 2.12047680 |
| 12 | MP0002060_abnormal_skin_morphology | 2.05424500 |
| 13 | MP0003941_abnormal_skin_development | 2.04055588 |
| 14 | MP0010368_abnormal_lymphatic_system | 1.98360038 |
| 15 | MP0005167_abnormal_blood-brain_barrier | 1.96774538 |
| 16 | MP0005623_abnormal_meninges_morphology | 1.94673183 |
| 17 | MP0005023_abnormal_wound_healing | 1.90839358 |
| 18 | MP0005508_abnormal_skeleton_morphology | 1.81920166 |
| 19 | MP0002877_abnormal_melanocyte_morpholog | 1.68652394 |
| 20 | MP0009250_abnormal_appendicular_skeleto | 1.58618018 |
| 21 | MP0001542_abnormal_bone_strength | 1.57103714 |
| 22 | MP0003566_abnormal_cell_adhesion | 1.54758450 |
| 23 | MP0000465_gastrointestinal_hemorrhage | 1.52982293 |
| 24 | MP0001879_abnormal_lymphatic_vessel | 1.47247940 |
| 25 | MP0006054_spinal_hemorrhage | 1.46168796 |
| 26 | MP0000534_abnormal_ureter_morphology | 1.45969792 |
| 27 | MP0003091_abnormal_cell_migration | 1.45529983 |
| 28 | MP0002108_abnormal_muscle_morphology | 1.44777330 |
| 29 | * MP0003385_abnormal_body_wall | 1.42412986 |
| 30 | MP0003950_abnormal_plasma_membrane | 1.37654349 |
| 31 | * MP0002168_other_aberrant_phenotype | 1.37280088 |
| 32 | MP0000013_abnormal_adipose_tissue | 1.35963312 |
| 33 | MP0009053_abnormal_anal_canal | 1.31196704 |
| 34 | MP0001346_abnormal_lacrimal_gland | 1.24629659 |
| 35 | MP0005388_respiratory_system_phenotype | 1.24285852 |
| 36 | MP0002133_abnormal_respiratory_system | 1.24285852 |
| 37 | MP0005670_abnormal_white_adipose | 1.23385304 |
| 38 | MP0003942_abnormal_urinary_system | 1.23111978 |
| 39 | MP0001915_intracranial_hemorrhage | 1.22804867 |
| 40 | MP0001849_ear_inflammation | 1.22452540 |
| 41 | MP0002896_abnormal_bone_mineralization | 1.22411134 |
| 42 | MP0000767_abnormal_smooth_muscle | 1.21226045 |
| 43 | MP0005164_abnormal_response_to | 1.20615284 |
| 44 | MP0000762_abnormal_tongue_morphology | 1.19929458 |
| 45 | MP0001348_abnormal_lacrimal_gland | 1.15363847 |
| 46 | MP0009780_abnormal_chondrocyte_physiolo | 1.12813429 |
| 47 | MP0010352_gastrointestinal_tract_polyps | 1.10176329 |
| 48 | MP0005390_skeleton_phenotype | 1.10074573 |
| 49 | MP0003191_abnormal_cellular_cholesterol | 1.09305260 |
| 50 | MP0001299_abnormal_eye_distance/ | 1.08603340 |
| 51 | MP0003828_pulmonary_edema | 1.08233481 |
| 52 | MP0000163_abnormal_cartilage_morphology | 1.06271472 |
| 53 | MP0001177_atelectasis | 1.05701430 |
| 54 | MP0005257_abnormal_intraocular_pressure | 1.04702541 |
| 55 | MP0000428_abnormal_craniofacial_morphol | 1.04273585 |
| 56 | MP0005595_abnormal_vascular_smooth | 1.03247170 |
| 57 | MP0000733_abnormal_muscle_development | 1.02651371 |
| 58 | MP0000343_altered_response_to | 1.02122302 |
| 59 | MP0004883_abnormal_blood_vessel | 1.01424432 |
| 60 | MP0005165_increased_susceptibility_to | 0.98930125 |
| 61 | MP0003186_abnormal_redox_activity | 0.98505234 |
| 62 | MP0002796_impaired_skin_barrier | 0.98426163 |
| 63 | MP0003806_abnormal_nucleotide_metabolis | 0.98366230 |
| 64 | MP0000751_myopathy | 0.97788479 |
| 65 | MP0003045_fibrosis | 0.97037136 |
| 66 | MP0002115_abnormal_skeleton_extremities | 0.95047654 |
| 67 | MP0005409_darkened_coat_color | 0.94508450 |
| 68 | MP0001243_abnormal_dermal_layer | 0.94111724 |
| 69 | MP0002925_abnormal_cardiovascular_devel | 0.91276284 |
| 70 | MP0001533_abnormal_skeleton_physiology | 0.89095082 |
| 71 | MP0004858_abnormal_nervous_system | 0.87618364 |
| 72 | MP0000249_abnormal_blood_vessel | 0.87402139 |
| 73 | MP0002282_abnormal_trachea_morphology | 0.85756246 |
| 74 | MP0003300_gastrointestinal_ulcer | 0.84789482 |
| 75 | MP0009115_abnormal_fat_cell | 0.83943268 |
| 76 | MP0005666_abnormal_adipose_tissue | 0.83403515 |
| 77 | MP0003115_abnormal_respiratory_system | 0.81336988 |
| 78 | MP0002932_abnormal_joint_morphology | 0.80976134 |
| 79 | MP0003935_abnormal_craniofacial_develop | 0.80860773 |
| 80 | MP0000750_abnormal_muscle_regeneration | 0.80768782 |
| 81 | MP0008007_abnormal_cellular_replicative | 0.80654538 |
| 82 | MP0003448_altered_tumor_morphology | 0.80334383 |
| 83 | MP0000003_abnormal_adipose_tissue | 0.80224050 |
| 84 | MP0000467_abnormal_esophagus_morphology | 0.80011496 |
| 85 | MP0000678_abnormal_parathyroid_gland | 0.79909110 |
| 86 | MP0000049_abnormal_middle_ear | 0.79482999 |
| 87 | MP0002249_abnormal_larynx_morphology | 0.79252296 |
| 88 | MP0002933_joint_inflammation | 0.78838382 |
| 89 | MP0004084_abnormal_cardiac_muscle | 0.78835419 |
| 90 | MP0005375_adipose_tissue_phenotype | 0.78691222 |
| 91 | MP0003724_increased_susceptibility_to | 0.78468556 |
| 92 | MP0001661_extended_life_span | 0.78215849 |
| 93 | MP0003755_abnormal_palate_morphology | 0.74953351 |
| 94 | MP0002128_abnormal_blood_circulation | 0.74901974 |
| 95 | * MP0005197_abnormal_uvea_morphology | 0.74840758 |
| 96 | MP0001270_distended_abdomen | 0.73676220 |
| 97 | MP0005171_absent_coat_pigmentation | 0.73198765 |
| 98 | MP0003868_abnormal_feces_composition | 0.73118769 |
| 99 | MP0002127_abnormal_cardiovascular_syste | 0.71717161 |
| 100 | MP0002998_abnormal_bone_remodeling | 0.70364156 |
| 101 | MP0003937_abnormal_limbs/digits/tail_de | 0.70112106 |
| 102 | MP0008004_abnormal_stomach_pH | 0.69931308 |
| 103 | MP0004130_abnormal_muscle_cell | 0.69739069 |
| 104 | MP0005193_abnormal_anterior_eye | 0.69368904 |
| 105 | MP0002113_abnormal_skeleton_development | 0.69334918 |
| 106 | MP0004185_abnormal_adipocyte_glucose | 0.68910011 |
| 107 | * MP0001614_abnormal_blood_vessel | 0.68798640 |
| 108 | MP0009379_abnormal_foot_pigmentation | 0.68292992 |
| 109 | MP0004782_abnormal_surfactant_physiolog | 0.67028968 |
| 110 | MP0005248_abnormal_Harderian_gland | 0.65541671 |
| 111 | MP0002233_abnormal_nose_morphology | 0.64561760 |
| 112 | MP0001175_abnormal_lung_morphology | 0.64294664 |
| 113 | MP0000538_abnormal_urinary_bladder | 0.63385175 |
| 114 | MP0006138_congestive_heart_failure | 0.62855084 |
| 115 | MP0002090_abnormal_vision | 0.59688362 |
| 116 | MP0000462_abnormal_digestive_system | 0.57961678 |
| 117 | MP0000858_altered_metastatic_potential | 0.57735254 |
| 118 | MP0003453_abnormal_keratinocyte_physiol | 0.55947296 |
| 119 | MP0009278_abnormal_bone_marrow | 0.55612961 |
| 120 | MP0000537_abnormal_urethra_morphology | 0.54968560 |
| 121 | MP0004134_abnormal_chest_morphology | 0.54347067 |
| 122 | MP0000749_muscle_degeneration | 0.54311052 |
| 123 | * MP0000759_abnormal_skeletal_muscle | 0.54145185 |
| 124 | MP0002177_abnormal_outer_ear | 0.54120644 |
| 125 | MP0002697_abnormal_eye_size | 0.54035300 |
| 126 | MP0000432_abnormal_head_morphology | 0.53300597 |
| 127 | MP0000613_abnormal_salivary_gland | 0.53217749 |
| 128 | MP0000266_abnormal_heart_morphology | 0.52918783 |
| 129 | MP0002138_abnormal_hepatobiliary_system | 0.52746213 |
| 130 | MP0005501_abnormal_skin_physiology | 0.52271753 |
| 131 | MP0004484_altered_response_of | 0.51774392 |
| 132 | MP0003075_altered_response_to | 0.50968871 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Protrusio acetabuli (HP:0003179) | 7.03377157 |
| 2 | Premature rupture of membranes (HP:0001788) | 6.49449317 |
| 3 | Aortic aneurysm (HP:0004942) | 5.14020082 |
| 4 | Broad metatarsal (HP:0001783) | 4.64722644 |
| 5 | Soft skin (HP:0000977) | 4.44293020 |
| 6 | Shallow orbits (HP:0000586) | 4.32279876 |
| 7 | Vascular tortuosity (HP:0004948) | 4.27535521 |
| 8 | Aortic dissection (HP:0002647) | 4.17281007 |
| 9 | Wrist flexion contracture (HP:0001239) | 4.12727960 |
| 10 | Ankle contracture (HP:0006466) | 4.06707458 |
| 11 | Dilatation of the ascending aorta (HP:0005111) | 3.88806592 |
| 12 | Arterial tortuosity (HP:0005116) | 3.80679666 |
| 13 | Atrophic scars (HP:0001075) | 3.73707653 |
| 14 | Bladder diverticulum (HP:0000015) | 3.68226681 |
| 15 | Cervical subluxation (HP:0003308) | 3.63710555 |
| 16 | Peritonitis (HP:0002586) | 3.61338445 |
| 17 | Wormian bones (HP:0002645) | 3.58617901 |
| 18 | Fragile skin (HP:0001030) | 3.53094496 |
| 19 | Follicular hyperkeratosis (HP:0007502) | 3.51342683 |
| 20 | Increased connective tissue (HP:0009025) | 3.41664996 |
| 21 | Spinal rigidity (HP:0003306) | 3.30701272 |
| 22 | Vertebral compression fractures (HP:0002953) | 3.20673344 |
| 23 | Aortic valve stenosis (HP:0001650) | 3.12797089 |
| 24 | Cerebral aneurysm (HP:0004944) | 3.11706728 |
| 25 | Abnormality of dentin (HP:0010299) | 3.09640835 |
| 26 | Hematochezia (HP:0002573) | 3.06541378 |
| 27 | Aplasia involving bones of the upper limbs (HP:0009823) | 2.97015064 |
| 28 | Aplasia of the phalanges of the hand (HP:0009802) | 2.97015064 |
| 29 | Aplasia involving bones of the extremities (HP:0009825) | 2.97015064 |
| 30 | Spontaneous hematomas (HP:0007420) | 2.86918642 |
| 31 | Type 1 muscle fiber predominance (HP:0003803) | 2.86364107 |
| 32 | Overgrowth (HP:0001548) | 2.85269281 |
| 33 | Neonatal short-limb short stature (HP:0008921) | 2.82925892 |
| 34 | Polycythemia (HP:0001901) | 2.78396776 |
| 35 | Biconcave vertebral bodies (HP:0004586) | 2.77421800 |
| 36 | Blue sclerae (HP:0000592) | 2.77250875 |
| 37 | Mitral valve prolapse (HP:0001634) | 2.74567075 |
| 38 | Short nail (HP:0001799) | 2.70325480 |
| 39 | Osteolytic defects of the hand bones (HP:0009699) | 2.66504396 |
| 40 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.66504396 |
| 41 | Esophageal varix (HP:0002040) | 2.65258912 |
| 42 | Conjunctival telangiectasia (HP:0000524) | 2.62985809 |
| 43 | Camptodactyly of toe (HP:0001836) | 2.57796649 |
| 44 | Nonimmune hydrops fetalis (HP:0001790) | 2.49309036 |
| 45 | Spinal cord lesions (HP:0100561) | 2.46510709 |
| 46 | Syringomyelia (HP:0003396) | 2.46510709 |
| 47 | Aneurysm (HP:0002617) | 2.45622955 |
| 48 | Bowel diverticulosis (HP:0005222) | 2.43704457 |
| 49 | Hyperextensible skin (HP:0000974) | 2.43151925 |
| 50 | Aortic regurgitation (HP:0001659) | 2.42757846 |
| 51 | Right ventricular cardiomyopathy (HP:0011663) | 2.38341051 |
| 52 | Mitral stenosis (HP:0001718) | 2.33556340 |
| 53 | Mesomelia (HP:0003027) | 2.27043385 |
| 54 | Wide anterior fontanel (HP:0000260) | 2.26309159 |
| 55 | Elbow flexion contracture (HP:0002987) | 2.26261886 |
| 56 | Hypoplasia of the iris (HP:0007676) | 2.25874745 |
| 57 | Coronal craniosynostosis (HP:0004440) | 2.21677339 |
| 58 | Buphthalmos (HP:0000557) | 2.21419081 |
| 59 | Acanthosis nigricans (HP:0000956) | 2.20868544 |
| 60 | Genu recurvatum (HP:0002816) | 2.20355476 |
| 61 | Spondylolisthesis (HP:0003302) | 2.18443255 |
| 62 | Tarsal synostosis (HP:0008368) | 2.17504309 |
| 63 | Venous insufficiency (HP:0005293) | 2.16024314 |
| 64 | Coxa vara (HP:0002812) | 2.14170124 |
| 65 | Short hallux (HP:0010109) | 2.12446462 |
| 66 | Abnormality of the acetabulum (HP:0003170) | 2.10997147 |
| 67 | Disproportionate tall stature (HP:0001519) | 2.10726582 |
| 68 | Bronchomalacia (HP:0002780) | 2.10049745 |
| 69 | Ovoid vertebral bodies (HP:0003300) | 2.09816526 |
| 70 | Knee flexion contracture (HP:0006380) | 2.08400813 |
| 71 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.07983277 |
| 72 | Abnormal hemoglobin (HP:0011902) | 2.06844387 |
| 73 | Reduced subcutaneous adipose tissue (HP:0003758) | 2.05202008 |
| 74 | Abnormal delivery (HP:0001787) | 2.05138873 |
| 75 | Abnormality of the nasal mucosa (HP:0000433) | 2.04608521 |
| 76 | Trismus (HP:0000211) | 2.02799908 |
| 77 | Joint laxity (HP:0001388) | 2.02595114 |
| 78 | Deviation of the hallux (HP:0010051) | 2.02352316 |
| 79 | Cardiovascular calcification (HP:0011915) | 2.01588460 |
| 80 | Ectopia lentis (HP:0001083) | 2.01552538 |
| 81 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.01398587 |
| 82 | Bell-shaped thorax (HP:0001591) | 2.00333528 |
| 83 | Spinal cord compression (HP:0002176) | 1.98246582 |
| 84 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.95339276 |
| 85 | Cerebral hemorrhage (HP:0001342) | 1.93817163 |
| 86 | Thin bony cortex (HP:0002753) | 1.93392417 |
| 87 | Alopecia of scalp (HP:0002293) | 1.93122067 |
| 88 | Aplasia/Hypoplasia of the hallux (HP:0008362) | 1.92999662 |
| 89 | Increased variability in muscle fiber diameter (HP:0003557) | 1.91738991 |
| 90 | Mitral regurgitation (HP:0001653) | 1.91658642 |
| 91 | Slender build (HP:0001533) | 1.91251386 |
| 92 | Ulnar bowing (HP:0003031) | 1.91239785 |
| 93 | Hallux valgus (HP:0001822) | 1.89870987 |
| 94 | Turricephaly (HP:0000262) | 1.89780027 |
| 95 | Neonatal death (HP:0003811) | 1.89752203 |
| 96 | Broad face (HP:0000283) | 1.89417588 |
| 97 | Asymmetry of the thorax (HP:0001555) | 1.89160458 |
| 98 | Infantile muscular hypotonia (HP:0008947) | 1.89157022 |
| 99 | Joint stiffness (HP:0001387) | 1.89083428 |
| 100 | Limited hip movement (HP:0008800) | 1.88689877 |
| 101 | Synostosis involving bones of the lower limbs (HP:0009138) | 1.87371705 |
| 102 | Synostosis involving bones of the feet (HP:0009140) | 1.87371705 |
| 103 | Joint contractures involving the joints of the feet (HP:0100492) | 1.86528430 |
| 104 | Flexion contracture of toe (HP:0005830) | 1.86528430 |
| 105 | Hip contracture (HP:0003273) | 1.85793175 |
| 106 | Abnormal cartilage morphology (HP:0002763) | 1.81609761 |
| 107 | Distal lower limb muscle weakness (HP:0009053) | 1.81532131 |
| 108 | Broad hallux (HP:0010055) | 1.81495174 |
| 109 | Round ear (HP:0100830) | 1.81376395 |
| 110 | Beaking of vertebral bodies (HP:0004568) | 1.81060707 |
| 111 | Abnormality of the anterior chamber (HP:0000593) | 1.80547739 |
| 112 | Fragile nails (HP:0001808) | 1.80545845 |
| 113 | Congenital glaucoma (HP:0001087) | 1.80349260 |
| 114 | Inguinal hernia (HP:0000023) | 1.80252805 |
| 115 | Fibular aplasia (HP:0002990) | 1.80241851 |
| 116 | Broad toe (HP:0001837) | 1.79773343 |
| 117 | Skull defect (HP:0001362) | 1.78699902 |
| 118 | Mucopolysacchariduria (HP:0008155) | 1.78600596 |
| 119 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.78600596 |
| 120 | Abnormality of the 2nd finger (HP:0004100) | 1.78040962 |
| 121 | Bowed forearm bones (HP:0003956) | 1.76478609 |
| 122 | Bowing of the arm (HP:0006488) | 1.76478609 |
| 123 | Natal tooth (HP:0000695) | 1.76256702 |
| 124 | Abnormal vertebral ossification (HP:0100569) | 1.75820618 |
| 125 | Striae distensae (HP:0001065) | 1.74638425 |
| 126 | Vertebral clefting (HP:0008428) | 1.74279017 |
| 127 | Broad ribs (HP:0000885) | 1.73781875 |
| 128 | Venous abnormality (HP:0002624) | 1.72848310 |
| 129 | Protruding ear (HP:0000411) | 1.72435650 |
| 130 | Osteopenia (HP:0000938) | 1.71851538 |
| 131 | Rectal prolapse (HP:0002035) | 1.70817228 |
| 132 | Abnormality of the intrinsic pathway (HP:0010989) | 1.70350019 |
| 133 | Menorrhagia (HP:0000132) | 1.70276581 |
| 134 | Delayed cranial suture closure (HP:0000270) | 1.68421159 |
| 135 | Pulmonary hypertension (HP:0002092) | 1.68032315 |
| 136 | Bradycardia (HP:0001662) | 1.68011513 |
| 137 | Flat cornea (HP:0007720) | 1.67792512 |
| 138 | Lymphangioma (HP:0100764) | 1.67357491 |
| 139 | Osteoarthritis (HP:0002758) | 1.66460612 |
| 140 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.66252166 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DDR2 | 4.51180012 |
| 2 | ERN1 | 4.02292943 |
| 3 | TRIB3 | 3.25120204 |
| 4 | TTN | 2.90692646 |
| 5 | EPHB2 | 2.84485368 |
| 6 | ERBB3 | 2.74211376 |
| 7 | LATS2 | 2.72449950 |
| 8 | PDGFRA | 2.57740895 |
| 9 | LATS1 | 2.43527827 |
| 10 | SIK1 | 2.23432569 |
| 11 | TESK1 | 2.04131761 |
| 12 | TRPM7 | 2.01779018 |
| 13 | FER | 2.01318774 |
| 14 | PAK2 | 1.95351613 |
| 15 | TGFBR1 | 1.94251315 |
| 16 | NEK9 | 1.86535797 |
| 17 | KDR | 1.76484473 |
| 18 | MAP3K3 | 1.72705423 |
| 19 | CAMK1D | 1.71444148 |
| 20 | RIPK1 | 1.69221038 |
| 21 | PIM2 | 1.65810935 |
| 22 | LIMK1 | 1.65772302 |
| 23 | FRK | 1.59852646 |
| 24 | TGFBR2 | 1.54968995 |
| 25 | MST1R | 1.50206834 |
| 26 | MOS | 1.45171219 |
| 27 | PTK2 | 1.42604608 |
| 28 | PAK3 | 1.40526333 |
| 29 | PAK4 | 1.38375951 |
| 30 | MYLK | 1.37125433 |
| 31 | FLT3 | 1.32828807 |
| 32 | MET | 1.31174174 |
| 33 | PKN2 | 1.28083282 |
| 34 | PTK6 | 1.26754653 |
| 35 | PTK2B | 1.26401795 |
| 36 | RPS6KA4 | 1.25752273 |
| 37 | LRRK2 | 1.23676678 |
| 38 | BMX | 1.22809521 |
| 39 | MAP2K1 | 1.22602409 |
| 40 | MAP3K12 | 1.21016901 |
| 41 | FES | 1.16241647 |
| 42 | LMTK2 | 1.15489184 |
| 43 | CDK6 | 1.07142553 |
| 44 | EPHA2 | 1.04485981 |
| 45 | BMPR1B | 1.04084782 |
| 46 | ROCK1 | 1.00838496 |
| 47 | BCKDK | 0.99676381 |
| 48 | STK3 | 0.99499769 |
| 49 | FGFR1 | 0.98599212 |
| 50 | CAMK1G | 0.98101403 |
| 51 | CDK8 | 0.96239413 |
| 52 | PIK3CA | 0.96162428 |
| 53 | PDK2 | 0.95175922 |
| 54 | PDGFRB | 0.92752421 |
| 55 | WNK1 | 0.85162825 |
| 56 | EPHA3 | 0.84402477 |
| 57 | EPHB1 | 0.83747680 |
| 58 | ILK | 0.81141081 |
| 59 | ROCK2 | 0.79621563 |
| 60 | FGFR2 | 0.78965922 |
| 61 | TAOK1 | 0.77353315 |
| 62 | MAPKAPK3 | 0.76960412 |
| 63 | STK38 | 0.76949407 |
| 64 | NME2 | 0.76494893 |
| 65 | PIK3CG | 0.74236036 |
| 66 | MAP2K2 | 0.72393226 |
| 67 | PAK6 | 0.70975374 |
| 68 | PRKD1 | 0.69825037 |
| 69 | MAP3K6 | 0.69633357 |
| 70 | RPS6KA2 | 0.69545955 |
| 71 | DMPK | 0.66598391 |
| 72 | ERBB4 | 0.65522501 |
| 73 | MTOR | 0.61724644 |
| 74 | NTRK1 | 0.61709182 |
| 75 | PDK4 | 0.61176284 |
| 76 | PDK3 | 0.61176284 |
| 77 | ZAK | 0.60709260 |
| 78 | DYRK1B | 0.60205080 |
| 79 | TAOK2 | 0.59994934 |
| 80 | GRK5 | 0.58482795 |
| 81 | MAP3K2 | 0.57936730 |
| 82 | EEF2K | 0.57920889 |
| 83 | ABL2 | 0.57535514 |
| 84 | MAPK7 | 0.55027028 |
| 85 | CDC42BPA | 0.54672300 |
| 86 | ZAP70 | 0.54504944 |
| 87 | PRKCH | 0.54089096 |
| 88 | SCYL2 | 0.52203134 |
| 89 | PRKD3 | 0.51936825 |
| 90 | SMG1 | 0.51727879 |
| 91 | TIE1 | 0.51564333 |
| 92 | IRAK3 | 0.50597084 |
| 93 | IGF1R | 0.47986944 |
| 94 | JAK3 | 0.47588309 |
| 95 | INSR | 0.47274372 |
| 96 | ARAF | 0.44878956 |
| 97 | MAPKAPK5 | 0.44652259 |
| 98 | MAP2K3 | 0.40478233 |
| 99 | SRC | 0.38378366 |
| 100 | PBK | 0.37484842 |
| 101 | GSK3A | 0.36712463 |
| 102 | PRKD2 | 0.36021195 |
| 103 | STK38L | 0.35982663 |
| 104 | DAPK3 | 0.35147487 |
| 105 | TEC | 0.34016824 |
| 106 | CAMK2G | 0.32091028 |
| 107 | CSK | 0.31278538 |
| 108 | NUAK1 | 0.30800362 |
| 109 | MAP3K7 | 0.30057098 |
| 110 | CAMKK1 | 0.29713845 |
| 111 | PRKCE | 0.29675181 |
| 112 | KSR2 | 0.29387701 |
| 113 | JAK1 | 0.29044243 |
| 114 | CDK9 | 0.28839412 |
| 115 | CLK1 | 0.28554564 |
| 116 | FGFR4 | 0.28480047 |
| 117 | PRKG2 | 0.28236513 |
| 118 | MAP3K11 | 0.28005996 |
| 119 | MAPKAPK2 | 0.27572287 |
| 120 | PAK1 | 0.27271625 |
| 121 | ABL1 | 0.26920230 |
| 122 | PLK2 | 0.26856732 |
| 123 | WNK4 | 0.26500930 |
| 124 | MELK | 0.25342609 |
| 125 | CAMK2B | 0.25211295 |
| 126 | MARK2 | 0.24054163 |
| 127 | EGFR | 0.23400283 |
| 128 | ADRBK1 | 0.23306105 |
| 129 | RET | 0.23059767 |
| 130 | PRKAA2 | 0.21102857 |
| 131 | FGFR3 | 0.19147102 |
| 132 | ICK | 0.18338245 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.47161493 |
| 2 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 3.35424859 |
| 3 | ECM-receptor interaction_Homo sapiens_hsa04512 | 3.17610403 |
| 4 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 3.09919983 |
| 5 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 3.07010348 |
| 6 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.72012874 |
| 7 | Focal adhesion_Homo sapiens_hsa04510 | 2.25933721 |
| 8 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.99096799 |
| 9 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.90457631 |
| 10 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.87520095 |
| 11 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.84520983 |
| 12 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.79968725 |
| 13 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.67584814 |
| 14 | Adherens junction_Homo sapiens_hsa04520 | 1.63502359 |
| 15 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 1.61622603 |
| 16 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.56575106 |
| 17 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.55822533 |
| 18 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.54489349 |
| 19 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.53522322 |
| 20 | Bladder cancer_Homo sapiens_hsa05219 | 1.49045743 |
| 21 | Malaria_Homo sapiens_hsa05144 | 1.45992097 |
| 22 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.45393988 |
| 23 | Retinol metabolism_Homo sapiens_hsa00830 | 1.44841442 |
| 24 | Other glycan degradation_Homo sapiens_hsa00511 | 1.42638422 |
| 25 | Hippo signaling pathway_Homo sapiens_hsa04390 | 1.41287020 |
| 26 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.38927365 |
| 27 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.37473916 |
| 28 | Amoebiasis_Homo sapiens_hsa05146 | 1.35886811 |
| 29 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.32999209 |
| 30 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.28601466 |
| 31 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.22386074 |
| 32 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.17992280 |
| 33 | Basal cell carcinoma_Homo sapiens_hsa05217 | 1.15356342 |
| 34 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.09964716 |
| 35 | Melanoma_Homo sapiens_hsa05218 | 1.09623206 |
| 36 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.08245227 |
| 37 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.07746034 |
| 38 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.05423862 |
| 39 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.03883900 |
| 40 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 1.01955367 |
| 41 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 1.00995177 |
| 42 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.99898689 |
| 43 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.99714218 |
| 44 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.95315803 |
| 45 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.92501708 |
| 46 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.92372266 |
| 47 | Pertussis_Homo sapiens_hsa05133 | 0.92029758 |
| 48 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.91061001 |
| 49 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.90839522 |
| 50 | Tight junction_Homo sapiens_hsa04530 | 0.90405688 |
| 51 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.90314341 |
| 52 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.89389332 |
| 53 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.87685689 |
| 54 | Endocytosis_Homo sapiens_hsa04144 | 0.87469206 |
| 55 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.85060741 |
| 56 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.83686361 |
| 57 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.82387546 |
| 58 | Phagosome_Homo sapiens_hsa04145 | 0.82058347 |
| 59 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.81440425 |
| 60 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.81170804 |
| 61 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.79731451 |
| 62 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.78211437 |
| 63 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.77852708 |
| 64 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.75056323 |
| 65 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.74826378 |
| 66 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.73255298 |
| 67 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.73247234 |
| 68 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.72940830 |
| 69 | Lysosome_Homo sapiens_hsa04142 | 0.72555177 |
| 70 | Galactose metabolism_Homo sapiens_hsa00052 | 0.70943743 |
| 71 | Viral myocarditis_Homo sapiens_hsa05416 | 0.70464194 |
| 72 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.70410774 |
| 73 | Prostate cancer_Homo sapiens_hsa05215 | 0.70388243 |
| 74 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.70082505 |
| 75 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.68880271 |
| 76 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.68563187 |
| 77 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.68513633 |
| 78 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.67080092 |
| 79 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.66944501 |
| 80 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.66743221 |
| 81 | Salmonella infection_Homo sapiens_hsa05132 | 0.65259666 |
| 82 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.63906232 |
| 83 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.63311101 |
| 84 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.62242016 |
| 85 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.61435530 |
| 86 | Pathways in cancer_Homo sapiens_hsa05200 | 0.60395355 |
| 87 | Axon guidance_Homo sapiens_hsa04360 | 0.59050248 |
| 88 | Thyroid cancer_Homo sapiens_hsa05216 | 0.58570376 |
| 89 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.57345395 |
| 90 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.56653921 |
| 91 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.56484504 |
| 92 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.55570859 |
| 93 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.52265047 |
| 94 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.51406748 |
| 95 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.51377177 |
| 96 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.50691260 |
| 97 | Insulin resistance_Homo sapiens_hsa04931 | 0.48983086 |
| 98 | Prion diseases_Homo sapiens_hsa05020 | 0.47892179 |
| 99 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.47229232 |
| 100 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.46517908 |
| 101 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.46431200 |
| 102 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.45734934 |
| 103 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.45420784 |
| 104 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.44477854 |
| 105 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.44250307 |
| 106 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.44063546 |
| 107 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.43702283 |
| 108 | Mineral absorption_Homo sapiens_hsa04978 | 0.42293535 |
| 109 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.42270417 |
| 110 | Gap junction_Homo sapiens_hsa04540 | 0.40402768 |
| 111 | Platelet activation_Homo sapiens_hsa04611 | 0.39752647 |
| 112 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.39547842 |
| 113 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.39073165 |
| 114 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.38976877 |
| 115 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.38492375 |
| 116 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.38265582 |
| 117 | Melanogenesis_Homo sapiens_hsa04916 | 0.38265446 |
| 118 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.38250941 |
| 119 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.38149250 |
| 120 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.38090943 |
| 121 | Colorectal cancer_Homo sapiens_hsa05210 | 0.37553707 |
| 122 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.37385110 |
| 123 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.36829048 |
| 124 | Shigellosis_Homo sapiens_hsa05131 | 0.36730936 |
| 125 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.36710340 |
| 126 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.36573285 |
| 127 | Apoptosis_Homo sapiens_hsa04210 | 0.36352549 |
| 128 | HTLV-I infection_Homo sapiens_hsa05166 | 0.35419842 |
| 129 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.34699584 |
| 130 | Bile secretion_Homo sapiens_hsa04976 | 0.33973433 |
| 131 | Glioma_Homo sapiens_hsa05214 | 0.33858685 |
| 132 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.33152157 |
| 133 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.32506558 |
| 134 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.32303028 |
| 135 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.29062964 |
| 136 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.28677353 |

